CNBC Television published this video item, entitled “Sanofi CEO says Dupixent eczema drug is game-changing for company” – below is their description.
“This is a once in a generation medicine,” Sanofi CEO Paul Hudson said of Dupixent, a therapy for allergic diseases such as eczema, asthma and nasal polyps that’s seeing rapid sales growth.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.